From: A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Male | 0.890 | 0.596–1.328 | 0.568 | – | – | – |
Age | 1.009 | 0.992–1.026 | 0.312 | – | – | – |
NYHA | 1.099 | 0.999–1.210 | 0.052 | – | – | – |
SBP | 0.988 | 0.981–0.996 | 0.002 | 0.995 | 0.980–1.011 | 0.561 |
DBP | 0.983 | 0.969–0.996 | 0.011 | 0.988 | 0.959–1.018 | 0.424 |
MM | 1.180 | 0.799–1.742 | 0.405 | – | – | – |
Hyperlipidemia | 0.847 | 0.555–1.294 | 0.443 | – | – | – |
Polyserositis | 1.273 | 0.856–1.894 | 0.233 | – | – | – |
Hemoglobin | 0.992 | 0.983–1.000 | 0.041 | 0.999 | 0.988–1.010 | 0.860 |
Atrial fibrillation | 1.047 | 0.656–1.673 | 0.847 | |||
ALB | 0.991 | 0.963–1.020 | 0.535 | – | – | – |
Calcium | 1.145 | 0.505–2.598 | 0.746 | – | – | – |
eGFR | 0.990 | 0.988–1.004 | 0.372 | – | – | – |
Cardiac troponin T | 1.001 | 1.000–1.002 | 0.134 | – | – | – |
NT-proBNP | 1.000 | 1.000–1.000 | 0.001 | 1.000 | 1.000–1.000 | 0.065 |
Chemotherapy | 0.571 | 0.382–0.853 | 0.006 | 0.803 | 0.481–1.341 | 0.402 |
LDL-C | 1.148 | 0.992–1.329 | 0.065 | – | – | – |
TC | 1.096 | 0.988–1.214 | 0.082 | – | – | – |
D-Dimer | 1.138 | 1.046–1.237 | 0.003 | 1.085 | 0.980–1.201 | 0.116 |
IVS | 1.089 | 1.037–1.143 | 0.001 | 1.191 | 1.033–1.373 | 0.016 |
LVPW | 1.084 | 1.023–1.149 | 0.007 | 0.911 | 0.785–1.058 | 0.222 |
LVEF | 0.971 | 0.952–0.990 | 0.003 | 0.965 | 0.942–0.988 | 0.003 |
Low voltage | 1.572 | 1.061–2.331 | 0.024 | 1.118 | 0.702–1.780 | 0.638 |
PRWP | 0.238 | 0.416–1.243 | 0.238 | – | – | – |
QRS duration | 1.001 | 0.994–1.007 | 0.865 | – | – | – |